Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Inspire Medical Systems, Inc.    INSP

INSPIRE MEDICAL SYSTEMS, INC.

(INSP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Inspire Medical : to Report Second Quarter 2020 Financial Results on August 4, 2020

share with twitter share with LinkedIn share with facebook
07/07/2020 | 08:01am EDT

MINNEAPOLIS, July 07, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, today announced that it will release financial results for the second quarter 2020 after the close of trading on Tuesday, August 4.  Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

Tuesday, August 4th @ 5:00 p.m. Eastern Time:
Domestic: 877-407-0792
International: 201-689-8263
Conference ID: 13706002
Webcast: http://public.viavid.com/index.php?id=140429

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
inspire@lifesciadvisors.com
646-597-6989

 


INSP Logo.png

Source: Inspire Medical Systems, Inc.

2020 GlobeNewswire, Inc., source Press Releases


share with twitter share with LinkedIn share with facebook
All news about INSPIRE MEDICAL SYSTEMS, INC.
09/24INSPIRE MEDICAL : to Report Third Quarter 2020 Financial Results on November 2, ..
AQ
09/24Inspire Medical Systems, Inc. to Report Third Quarter 2020 Financial Results ..
GL
09/02Inspire Medical Systems, Inc. to Present at the Wells Fargo 2020 Virtual Heal..
GL
09/01Inspire Medical Systems, Inc. Announces Humana Coverage for Inspire Therapy
GL
08/17Inspire Medical Systems, Inc. Announces Two Additional Coverage Policies from..
GL
08/12Inspire Medical Systems, Inc. Announces Regulatory Approval of Inspire Therap..
GL
08/05INSPIRE MEDICAL SYSTEMS, INC. : Regulation FD Disclosure (form 8-K)
AQ
08/04INSPIRE : 2Q Earnings Snapshot
AQ
08/04INSPIRE MEDICAL : Management's Discussion and Analysis of Financial Condition an..
AQ
08/04INSPIRE MEDICAL SYSTEMS, INC. : Results of Operations and Financial Condition (f..
AQ
More news
Financials (USD)
Sales 2020 90,2 M - -
Net income 2020 -72,9 M - -
Net cash 2020 161 M - -
P/E ratio 2020 -43,8x
Yield 2020 -
Capitalization 3 290 M 3 290 M -
EV / Sales 2020 34,7x
EV / Sales 2021 21,8x
Nbr of Employees 239
Free-Float 96,2%
Chart INSPIRE MEDICAL SYSTEMS, INC.
Duration : Period :
Inspire Medical Systems, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INSPIRE MEDICAL SYSTEMS, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 127,31 $
Last Close Price 122,76 $
Spread / Highest target 22,2%
Spread / Average Target 3,70%
Spread / Lowest Target -59,3%
EPS Revisions
Managers
NameTitle
Timothy P. Herbert President, CEO, Secretary & Director
Marilyn Carlson Nelson Chairman
Philip J. Ebeling Chief Operating Officer
Richard John Buchholz Chief Financial Officer
Quan Ni Vice President-Research
Sector and Competitors